Zelluna ASA (OB: ZLNA)
Health Care · Biotechnology · NO
Nkr18.50
-5.85% today · +60.9% 1Y
Zelluna ASA (OB: ZLNA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $58.51M and employs 15 people.
Over the last twelve months the share price has gained 60.9%, trading between 8.20 and 35.80.
Tweenvest scores Zelluna ASA across four factors: quality 37/100, value 62/100. Its strongest factor is value.
ZLNA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $58.51M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -4.80
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Nkr35.80
- 52-week low
- Nkr8.20
- Avg volume (3M)
- —
- Shares outstanding
- 29.86M
- Employees
- 15
- Next earnings
- —
About Zelluna ASA
Established in 2016 and headquartered in Oslo, Norway, Zelluna ASA specializes in the creation of T-cell receptor (TCR) cellular immunotherapy treatments aimed at combating solid tumors.
- ISIN
- NO0013524942
- Founded
- 2016
- Listed since
- Jun 3, 2019
- Exchange
- Oslo Bors
- Currency
- NOK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| OS Therapies IncorporatedNYSEAM: OSTX | $60.89M | $1.32 | -18.52% |
| Pharos iBio Co., Ltd.KOSDAQ: A388870 | $60.30M | ₩6,210.00 | -3.12% |
| Hemogenyx Pharmaceuticals PlcLSE: HEMO | $59.69M | £6.58 | -10.48% |
| Gossamer Bio, Inc.NasdaqGS: GOSS | $58.75M | $9.61 | +1.53% |
| Adaptin Bio, Inc.OTCPK: APTN | $57.89M | $— | — |
| Biosino Bio-Technology and Science IncorporationSEHK: 8247 | $57.71M | HK$3.13 | -0.32% |
| B&K Corporation LimitedSEHK: 2396 | $57.42M | HK$3.83 | -8.70% |
| Caribou Biosciences, Inc.NasdaqGS: CRBU | $57.12M | $0.53 | -4.86% |
Figures last refreshed Oct 18, 2026.